We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Information for patients, public and healthcare professionals.
Information for patients, public and healthcare professionals
The MHRA has today, 26 November 2025, approved inavolisib (Itovebi) for the treatment of adults with a type of breast cancer called HR-positive
New Cosmetic Breast Augmentation Risk Awareness Tool for patients to use when considering cosmetic breast implant surgery.
Patients will receive faster diagnosis, quicker treatment and the support to live well with cancer under the government’s landmark new National Cancer Plan.
1 and 5 year survival for adults diagnosed with cancer of the oesophagus, stomach, colon, lung, breast or cervix between 1997 and 2012.
Information for clinicians and patients.
1-year cancer survival by Clinical Commissioning Group for all-cancers combined, breast, colorectal and lung from 2003 to 2018 followed up to 2019.
Training and continuing professional development (CPD) for people working in the NHS breast screening programme (BSP) in England.
These publications explain breast screening and support the NHS Breast Screening Programme.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).